Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
153.40    0.90 (0.59%)
Bid:
153.30
Ask:
153.60
Spread: 0.30 (0.196%)
Market Cap: £1.59b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

2022 AGM Results - update statement

6 Mar 2023 11:05

RNS Number : 0055S
Currys PLC
06 March 2023
 

6 March 2023

CURRYS PLC

 

Further statement in relation to the AGM vote on our Directors' Remuneration Policy

 

The Board of Currys plc ('the Company') welcomed the 65.9% vote in favour of our Directors' Remuneration Policy at the Annual General Meeting ("AGM") held on 8 September 2022 but acknowledged that a minority of shareholders did not support this resolution.

 

The Company explained in its AGM Results announcement the action it intended to take to understand and address shareholder concerns and an update is provided below.

 

Since the AGM, the Company has sought further engagement with our largest shareholders to discuss the specific rationale for the votes against our report. This engagement included the Chair of the Remuneration Committee meeting with some of our largest shareholders and writing to other shareholders representing 67% of the Company's share capital, inviting them to meet with the Chair and or provide feedback.

 

Following careful consideration of all feedback received, the Company's Remuneration Committee and the Board have agreed to increase the post-employment shareholding requirement. Directors will be required to retain at least 100% of their Currys plc shares for two years post employment (the lower of actual shareholding or the shareholding requirement immediately prior to departure - in line with IA guidelines). The requirement to date has been for directors to retain at least 100% of their Currys plc shares for one year then at least 50% in the following year. This new post-employment shareholding is effective immediately notwithstanding the wording in the current Directors' Remuneration Policy. The Committee intends to formally incorporate this post-employment shareholding requirement into the binding Remuneration Policy the next time that an amended version is put to a shareholder vote. The Committee will also continue to annually review the weight of financial measures in both the short and long-term incentives as part of its ongoing remuneration activities.

The Company's Remuneration Committee and the Board continue to believe that the Company's Directors' Remuneration Policy is appropriate in the context of incentivising our executive team, as they continue to deliver the Group's strategy.

 

The Company will continue to engage with shareholders and will provide an update in the Company's 2023 Annual Report and Accounts.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBQLFBXXLFBBX
Date   Source Headline
3rd Jun 20267:00 amRNSFredrik Tønnesen appointed Group Chief Executive
1st Jun 20269:36 amRNSTotal Voting Rights
19th May 202611:09 amRNSDirector Declaration
19th May 20267:00 amRNSPerformance continues to strengthen
12th May 20264:56 pmRNSHolding(s) in Company
11th May 202612:04 pmRNSHolding(s) in Company
1st May 20264:34 pmRNSTotal Voting Rights
1st May 20264:31 pmRNSHolding(s) in Company
30th Apr 202610:01 amRNSHolding(s) in Company
14th Apr 202610:56 amRNSHolding(s) in Company
13th Apr 20269:34 amRNSHolding(s) in Company
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:31 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20269:20 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20268:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:29 pmRNSHolding(s) in Company
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSAlex Baldock to step down as Group Chief Executive
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20262:25 pmRNSHolding(s) in Company
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20269:15 amRNSHolding(s) in Company
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202610:03 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 202610:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.